Investigator Disclosure Guidance Emphasizes Spouses, Children

Final FDA guidance on clinical investigator financial disclosures underscores that the term “clinical investigator” includes the spouse and children of the investigator, as well as subinvestigators participating in a study. It also makes the distinction that an applicant is not necessarily the sponsor, although it can be, but rather the party that submitted the marketing application.
Washington Drug Letter